Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05703191 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Real-world Study of Nitric Oxide Generator and Delivery System

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 19, 2025 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 31, 2023 to Mar 31, 2025
    • Study completion date: May 31, 2023 to May 31, 2025
    • Eligibility criteria shortened, about 1 word
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 1, 2023 to Feb 3, 2023
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Novlead Inc.
5 trials monitored
See all monitored trials
Hypertension
1,925 trials monitored
See 99 trials at risk
The study is aimed to observe the efficacy and safety of Nitric Oxide Generator and Delivery System in Pulmonary Hypertension of Newborn in real clinical settings.
Trial Details
NCT Number NCT05703191
Lead Sponsor Novlead Inc.
Conditions
(from sponsor)		 Pulmonary Hypertension of Newborn
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov